Diana V. Do, MD and colleagues discuss late-breaking data from the LIGHTSIGHT III
clinical trial on photobiomodulation (PBM) in dry AMD, with a high-level overview of PBM technology.
Will this technology provide meaningful improvements in patients’ vision?
Hear what the experts have to say live from the Retina Society Meeting in this 5-minute video.
KOL VIDEOS live from the Retina Society Meeting in this 15-minute video.
OAKS and DERBY: Efficacy and Safety Data Summary live from the Retina Society Meeting in this 11-minute video.